CD300LF and acute myeloid leukemia: Consistently, when examining the expression differences of CD300s across published molecular subtypes in the Hemap AML dataset, we found that CD300A‐CD300LF were more highly expressed in monocyte‐like AML, with low‐expressions levels in the PML‐RARA subtype (Figure 6B).